Literature DB >> 2799390

The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

J D Mellentin1, C Murre, T A Donlon, P S McCaw, S D Smith, A J Carroll, M E McDonald, D Baltimore, M L Cleary.   

Abstract

The gene (E2A) that codes for proteins with the properties of immunoglobulin enhancer binding factors E12/E47 was mapped to chromosome region 19p13.2-p13.3, a site associated with nonrandom translocations in acute lymphoblastic leukemias. The majority of t(1;19)(q23;p13)-carrying leukemias and cell lines studied contained rearrangements of E2A as determined by DNA blot analyses. The rearrangements altered the E2A transcriptional unit, resulting in the synthesis of a transcript larger than the normal-sized E2A mRNAs in one of the cell lines with this translocation. These observations indicate that the gene for a transcription factor is located at the breakpoint of a consistently recurring chromosomal translocation in many acute leukemias and suggest a direct role for alteration of such factors in the pathogenesis of some malignancies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2799390     DOI: 10.1126/science.2799390

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers.

Authors:  B Corneliussen; A Thornell; B Hallberg; T Grundström
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

Review 5.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

6.  The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.

Authors:  S Scheidler; W J Fredericks; F J Rauscher; F G Barr; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  A gene fusion at a homeobox locus: alterations in leaf shape and implications for morphological evolution.

Authors:  J J Chen; B J Janssen; A Williams; N Sinha
Journal:  Plant Cell       Date:  1997-08       Impact factor: 11.277

8.  A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.

Authors:  David Y Zhang; Nicolas Goossens; Jinsheng Guo; Ming-Chao Tsai; Hsin-I Chou; Civan Altunkaynak; Angelo Sangiovanni; Massimo Iavarone; Massomo Colombo; Masahiro Kobayashi; Hiromitsu Kumada; Augusto Villanueva; Josep M Llovet; Yujin Hoshida; Scott L Friedman
Journal:  Gut       Date:  2015-06-04       Impact factor: 23.059

9.  Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).

Authors:  Ryosuke Shirasaki; Haruko Tashiro; Yoko Oka; Toshihiko Sugao; Tadashi Yamamoto; Mayumi Yoshimi; Nobu Akiyama; Kazuo Kawasugi; Naoki Shirafuji
Journal:  Int J Hematol       Date:  2011-07-06       Impact factor: 2.490

10.  ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.

Authors:  Annette M May; Anna-Verena Frey; Lioudmila Bogatyreva; Marco Benkisser-Petersen; Dieter Hauschke; Michael Lübbert; Ralph Wäsch; Martin Werner; Jens Hasskarl; Silke Lassmann
Journal:  Histochem Cell Biol       Date:  2013-11-30       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.